ARMC
VCYT icon

American Research & Management Company’s Veracyte VCYT Stock Holding History

American Research & Management Company’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1K Hold
50
– – ﹤0.01% 412
2022
Q2 		$1K Hold
50
– – ﹤0.01% 388
2022
Q1 		$1K Hold
50
– – ﹤0.01% 393
2021
Q4 		$2K Hold
50
– – ﹤0.01% 368
2021
Q3 		$2K Hold
50
– – ﹤0.01% 359
2021
Q2 		$2K Buy
+50
New +$2.14K ﹤0.01% 364

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

American Research & Management Company's VCYT Position: Q3 2022 in Review

American Research & Management Company held its Veracyte (VCYT) position steady in Q3 2022 at 50 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #412.

American Research & Management Company first reported a position in VCYT in Q2 2021 and has held it in 6 quarters since. The position peaked at $2K in Q4 2021. 208 funds tracked by Wall St. Rank hold VCYT as of Q3 2022.

  • American Research & Management Company held 50 shares of Veracyte worth $1K as of Q3 2022.
  • American Research & Management Company left its Veracyte share count unchanged in Q3 2022.
  • Veracyte made up ﹤0.01% of American Research & Management Company's portfolio in Q3 2022, its #412 holding.
  • American Research & Management Company first reported a position in Veracyte in Q2 2021 and has held it in 6 quarters since.
  • American Research & Management Company's Veracyte position peaked at $2K in Q4 2021.
  • 208 funds tracked by Wall St. Rank held Veracyte as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.